RA-ILD ? new insights into disease burden from an international patient survey - Milan 2023

New tools for risk assessment in the interstitial lung disease setting

Chair(s): Diego Castillo Villegas, Fabio Arimura

Session type: Poster session

RA-ILD ? new insights into disease burden from an international patient survey

Michael Kreuter

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Factors prognostic of rapid progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Oliver Distler

Poster

Abstract

ILD progression varies in subtypes of connective tissue diseases

Phuong Phuong Diep

Poster

Abstract

Late Breaking Abstract - Characterization of high responders in the phase 2a IPF AIR trial of C21 using baseline quantitative CT image analysis

Elliott Bussell

Poster

Abstract

Late Breaking Abstract - AI-powered decision support helps pulmonologists to diagnose ILD more accurately.

Julie Maes

Poster

Abstract

Malaysian real-world data to describe progressive pulmonary fibrosis (PPF) in a clinical setting

Syazatul Syakirin Sirol Aflah

Poster

Abstract

ILD associated with systemic sclerosis: predisposing factors for progressive fibrosing ILD

Sheila Ramjug

Poster

Abstract

Interstitial lung disease in connective tissue disease: data from an Italian Multidisciplinary Unit

Alberto Bracciali

Poster

Abstract

Screening for ILD in RA: a survey of 1132 patients with RA

Anna Maria Hoffmann-vold

Poster

Abstract

Argentine registry of autoimmune interstitial lung disease: EPIMAR 2 baseline data

Juan Ignacio Enghelmayer

Poster

Abstract

Decline in BMI is a predictor of functional progression in pulmonary fibrosis associated with connective tissue disease

Alexandra Nagy

Poster

Abstract

PF-ILD and PPF criteria as predictors for mortality in RA-ILD

Phuong Phuong Diep

Poster

Abstract

The natural history of interstitial pneumonia with autoimmune features compared to connective tissue disease-associated interstitial lung disease prospective single-centre study preliminary results

Ewa Miadlikowska

Poster

Abstract

The Feasibility of Home Spirometry and Oximetry Monitoring In Patients With Interstitial Lung Disease

Wan Lin Ng

Poster

Abstract

Real world incidence & prevalence of PF-ILD in a systemic sclerosis cohort

Mahin Ahmad

Poster

Abstract

Risk factors for SSc-ILD progression using the new PPF guideline and INBUILD PF-ILD criteria

Oliver Distler

Poster

Abstract

Clinical score composite of DLCO, mMRC, and 6-mnute walking distance provides prognostic value in patients with fibrotic lung disease: A Prospective observationl Study

Pin-kuei Fu

Poster

Abstract

RA-ILD new insights into disease burden from an international patient survey

Michael Kreuter

Poster

Abstract

Living with chronic cough: experiences, burden and management in ILD a qualitative Study

Shirley Quach

Poster

Abstract

Functional improvement at one year in fibrotic interstitial lung diseases (ILD) impact of baseline biomarkers and anti-inflammatory therapies

Guangyu Shao

Poster

Abstract

Late Breaking Abstract - Inhaled pirfenidone (AP01) forced vital capacity (FVC) data from the ATLAS study vs placebo from 3 historical idiopathic pulmonary fibrosis (IPF) randomised controlled trials (RCTs)

Nazia Chaudhuri

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}